A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Asthma attacks and COPD flare-ups (also called ... It is currently used for the treatment of severe asthma. The ABRA trial has found a single dose can be more effective when injected at the ...

An injection given during some asthma and COPD attacks is more effective than ... It is currently used for the treatment of severe asthma. The ABRA trial has found a single dose can be more ...

Earlier this year, researchers of Brigham and Women’s Hospital Harvard Medical School looked at clinical trials to show how six biologics, in particular, improve lung function; cut down on steroid use ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

Scientists say this is the first new way of treating the attacks in 50 years despite 3.8 million deaths across the world ...

If a person has a severe asthma attack, they need to go to the hospital right away. Asthma attacks can be life threatening, especially when a person’s asthma does not respond well to treatment.

Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used for the treatment of severe asthma.

Researchers have found that an injection given during some asthma ... treatment and hospitalisations during attacks. Benralizamab is a monoclonal antibody currently used to treat severe asthma ...

The first new treatment for asthma attacks in 50 years has been hailed ... life-threatening breathing difficulties in people with a severe form of the disease. The monoclonal antibody specifically ...